Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3 publications
Efficacy and Safety of Single Oral Dosing of Secnidazole for Trichomoniasis in Women: Results of a Phase 3, Randomized, Double-Blind, Placebo-Controlled, Delayed-Treatment Study.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: January 12, 2021
A phase 3, randomized, controlled trial of Astodrimer 1% Gel for preventing recurrent bacterial vaginosis.
Journal: European journal of obstetrics & gynecology and reproductive biology: X
Published: September 30, 2020
Two phase 3, double-blind, placebo-controlled studies of the efficacy and safety of Astodrimer 1% Gel for the treatment of bacterial vaginosis.
Journal: European journal of obstetrics, gynecology, and reproductive biology
Published: August 05, 2019
Showing 1-3 of 3
Last Updated: 09/26/2026